The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Senate Hearing Highlights the Good, the Bad, and The Ugly of RRB
- On-Duty Assault Leaves Amtrak Conductor Facing Financial Hardship
- Transit Equity Day: Remembering Rosa Parks
- Railroads Have Short Memories: East Palestine 3 Years Later
- RIDER Safety ACT Aims to Curb Transit Assaults Nationwide
- Rail Safety Is Too Important For Corporate Discretion
- Virginia 2-PC Law Could Become a Reality if We Act Now
- WATCH: Members Step Up to Take Care of Their Own
- Metro Micro Operators Overwhelmingly Ratify First Contract
- New Documentary Features California Local 1741 Bus Operators